Actively Recruiting

Phase Not Applicable
Age: 70Years +
All Genders
NCT03296150

ADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGE

Led by Hospices Civils de Lyon · Updated on 2024-05-03

139

Participants Needed

9

Research Sites

413 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

As the proportion of oral anticancer treatments is continuously increasing, adherence appears as a major issue for patients' outcomes. Poor adherence affects particularly geriatric patients due among others to polypharmacy or cognitive impairment. Thus, the need for educational programs in this population has been regularly emphasized. PRESTAGE educational program was built after an external and internal analysis of educational needs in elderly patients treated with oral cancer treatments. It implicates a multidisciplinary educational team (nurses, physicians, pharmacists, psychologists, physiologists, social workers...). Six educational workshops were designed with the following endpoints: disease and treatment understanding, treatment management, nutrition and psychological as well as physical well being. ADOPT-PRESTAGE is a clinical, prospective, interventional, open-label, multicenter, randomized, controlled trial designed to evaluate the impact of PRESTAGE program. It is, to the investigators' knowledge, the first randomized controlled trial evaluating the acceptability and impact (adherence, clinical benefit) of an educational program in an elderly cancer population. The primary endpoint of this trial will be to evaluate adherence using an indirect objective adherence measure: the Medication Event Monitoring System (MEMS). Secondary endpoints include quality of life and evaluation of changes in patients' behaviors.

CONDITIONS

Official Title

ADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGE

Who Can Participate

Age: 70Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients older than 70 years
  • Oral anticancer therapy started within the previous 45 days or planned within 45 days
  • Any type of cancer, solid or hematologic, any stage
  • Estimated life expectancy greater than 6 months
  • Affiliated to social security or equivalent
  • Able to answer questionnaires and protocol evaluations
  • Signed informed consent
  • Living within 50 km of the investigating center
Not Eligible

You will not qualify if you...

  • Breast cancer patients receiving only hormone therapy
  • Prostate cancer patients on first-generation hormone therapy
  • Unavailable for regular follow-up due to geographic, family, social, or psychological reasons
  • Serious physical or mental condition causing permanent disability preventing treatment
  • Patient deprived of liberty or under guardianship

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Service de neuro-oncologie, Hôpital Pierre Wertheimer, HCL

Bron, France, 69500

Actively Recruiting

2

Service de Gériatrie, Centre Hospitalier de Givors

Givors, France, 69700

Withdrawn

3

Service d'oncologie médicale, Centre Hospitalier Universitaire de Grenbole

La Tronche, France, 38700

Withdrawn

4

Service de Médecine du vieillissement, Hôpital Edouard Herriot, HCL

Lyon, France, 69003

Actively Recruiting

5

Service de médecine du vieillissement, Hôpital de la Croix-Rousse, HCL

Lyon, France, 69004

Actively Recruiting

6

Service d'oncologie médicale, Cnetre Léon Bérard

Lyon, France, 69373 cedex 08

Not Yet Recruiting

7

Service d'oncologie, Centre Hospitalier Annecy Genevois

Metz-Tessy, France, 74370

Not Yet Recruiting

8

Service de Médecine du vieillissement, Centre Hospitalier Lyon Sud (Hospices Civils de Lyon)

Pierre-Bénite, France, 69310

Actively Recruiting

9

service de gériatrie, Hôpital de la Charité, Centre Hospitalier Universitaire de St-Etienne

Saint-Etienne, France, 42100

Withdrawn

Loading map...

Research Team

O

Olivia LE SAUX

CONTACT

C

Claire FALANDRY, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here